- Home
- ITRM vs BASE Comparison
ITRM vs BASE Comparison
Compare ITRM & BASE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRM
- BASE
- Stock Information
- Founded
- ITRM 2015
- BASE 2011
- Country
- ITRM Ireland
- BASE United States
- Employees
- ITRM N/A
- BASE N/A
- Industry
- ITRM Biotechnology: Pharmaceutical Preparations
- BASE EDP Services
- Sector
- ITRM Health Care
- BASE Technology
- Exchange
- ITRM Nasdaq
- BASE Nasdaq
- Market Cap
- ITRM 40.0M
- BASE 1.3B
- IPO Year
- ITRM 2018
- BASE 2021
- Fundamental
- Price
- ITRM $0.66
- BASE $24.43
- Analyst Decision
- ITRM Strong Buy
- BASE Hold
- Analyst Count
- ITRM 1
- BASE 15
- Target Price
- ITRM $9.00
- BASE $23.29
- AVG Volume (30 Days)
- ITRM 699.1K
- BASE 728.5K
- Earning Date
- ITRM 11-13-2025
- BASE 09-03-2025
- Dividend Yield
- ITRM N/A
- BASE N/A
- EPS Growth
- ITRM N/A
- BASE N/A
- EPS
- ITRM N/A
- BASE N/A
- Revenue
- ITRM N/A
- BASE $220,639,000.00
- Revenue This Year
- ITRM N/A
- BASE $12.14
- Revenue Next Year
- ITRM $482.25
- BASE $14.38
- P/E Ratio
- ITRM N/A
- BASE N/A
- Revenue Growth
- ITRM N/A
- BASE 10.97
- 52 Week Low
- ITRM $0.61
- BASE $12.78
- 52 Week High
- ITRM $3.02
- BASE $25.16
- Technical
- Relative Strength Index (RSI)
- ITRM 41.52
- BASE 66.17
- Support Level
- ITRM $0.66
- BASE $24.35
- Resistance Level
- ITRM $0.76
- BASE $24.50
- Average True Range (ATR)
- ITRM 0.05
- BASE 0.04
- MACD
- ITRM 0.01
- BASE -0.02
- Stochastic Oscillator
- ITRM 41.81
- BASE 53.33
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About BASE Couchbase Inc.
Couchbase Inc provides a modern cloud database that offers the robust capabilities required for business-critical applications on a scalable and available platform. It empower developers and architects to build, deploy and run mission-critical applications. Couchbase delivers a high-performance, flexible and scalable modern database that runs across the data center and any cloud. Geographically, the company generates a majority of its revenue from the United States.